1-182056778-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001009992.1(ZNF648):āc.1233G>Cā(p.Gln411His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,559,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00012 ( 0 hom., cov: 33)
Exomes š: 0.0000064 ( 0 hom. )
Consequence
ZNF648
NM_001009992.1 missense
NM_001009992.1 missense
Scores
2
5
12
Clinical Significance
Conservation
PhyloP100: 1.25
Genes affected
ZNF648 (HGNC:18190): (zinc finger protein 648) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription, DNA-templated. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18408921).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF648 | NM_001009992.1 | c.1233G>C | p.Gln411His | missense_variant | 2/2 | ENST00000339948.3 | NP_001009992.1 | |
ZNF648 | XM_024453260.2 | c.1233G>C | p.Gln411His | missense_variant | 3/3 | XP_024309028.1 | ||
ZNF648 | XM_047445722.1 | c.1233G>C | p.Gln411His | missense_variant | 4/4 | XP_047301678.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF648 | ENST00000339948.3 | c.1233G>C | p.Gln411His | missense_variant | 2/2 | 1 | NM_001009992.1 | ENSP00000344129.3 | ||
ZNF648 | ENST00000673963.1 | c.678G>C | p.Gln226His | missense_variant | 2/2 | ENSP00000501285.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152044Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
18
AN:
152044
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000124 AC: 2AN: 161088Hom.: 0 AF XY: 0.0000233 AC XY: 2AN XY: 85678
GnomAD3 exomes
AF:
AC:
2
AN:
161088
Hom.:
AF XY:
AC XY:
2
AN XY:
85678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000640 AC: 9AN: 1407048Hom.: 0 Cov.: 31 AF XY: 0.00000719 AC XY: 5AN XY: 694928
GnomAD4 exome
AF:
AC:
9
AN:
1407048
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
694928
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152044Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74274
GnomAD4 genome
AF:
AC:
18
AN:
152044
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74274
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2023 | The c.1233G>C (p.Q411H) alteration is located in exon 2 (coding exon 1) of the ZNF648 gene. This alteration results from a G to C substitution at nucleotide position 1233, causing the glutamine (Q) at amino acid position 411 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
B
Vest4
MutPred
Gain of catalytic residue at Q411 (P = 0.0623);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at